DNA-reactive protein monoepoxides induce cell death and mutagenesis in mammalian cells

Natalia Y Tretyakova1, Erin D Michaelson-Richie, Teshome B Gherezghiher

  • 1Department of Medicinal Chemistry and Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.

Biochemistry
|April 10, 2013
PubMed

Insights

Cytotoxic alkylating agents form DNA-protein cross-links (DPCs), which are poorly understood. This study shows that DPCs are toxic and mutagenic, contributing to the effects of these agents.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Cytotoxic alkylating agents are used in cancer therapy but their precise mechanisms of action remain unclear.
  • These agents form various DNA lesions, including DNA-protein cross-links (DPCs), whose biological impact is largely unknown.
  • Understanding DPCs is crucial for developing more effective and targeted cancer therapies.

Purpose of the Study:

  • To investigate the biological consequences of DNA-protein cross-link (DPC) formation.
  • To determine the role of DPCs in the cytotoxicity and mutagenesis induced by bis-electrophilic agents.
  • To elucidate the contribution of DPCs to the overall toxicity of alkylating agents.

Main Methods:

  • Generation of DNA-reactive protein reagents using epoxide-functionalized O(6)-alkylguanine DNA alkyltransferase (AGT).
  • Confirmation of covalent DPC formation using gel shift and mass spectrometry.
  • Introduction of purified AGT monoepoxides into mammalian cells via electroporation to assess toxicity and mutagenesis.

Main Results:

  • Epoxide-functionalized AGT proteins formed covalent DPCs with DNA but no other DNA lesions.
  • Introduction of AGT monoepoxides into cells induced DPCs, cell death, and mutations.
  • Reduced DPC formation and cell death were observed with an AGT variant that does not accumulate in the nucleus, indicating nuclear DNA damage is critical.

Conclusions:

  • Covalent DNA-protein cross-links (DPCs) generated by AGT monoepoxides are cytotoxic and mutagenic in mammalian cells.
  • These DPCs contribute to the toxicity and mutagenic effects of bis-electrophilic agents.
  • Nuclear DNA damage is essential for the observed toxicity, highlighting the importance of DPCs in chromosomal DNA.

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...